Bottom line
Is SWISX a good fund? The bottom line
SWISX is an index international stock mutual fund from Schwab.
Its expense ratio is 0.06% — about $6 a year on every $10,000 invested, cheaper than 96% of international stock funds we track.
It returned +31.6% over one year, +9.0% a year over five years, +8.3% a year over ten (as of Dec 31, 2025, per its prospectus).
With $13.6 billion in net assets and 697 holdings, its largest position is ASML Holding NV (2.6%) and the top 10 make up 13.3% of the portfolio.
The closest lower-cost alternative we found is FSPSX (0.035%, 80% top-holdings overlap).
What stands out
- Low cost: cheaper than 96% of international stock peers
- 5-year return beat 75% of category peers
- Broadly diversified (697 holdings)
- Large and established ($13.6 billion)
Updated Nov 19, 2026
What SWISX invests in
The funds goal is to track the performance of a benchmark index that measures the total return of large, publicly traded non-U.S. companies from countries with developed equity markets outside of the United States.
To pursue its goal, the fund generally invests in stocks that are included in the MSCI EAFE Index . Index ownership MSCI EAFE is a registered mark of MSCI and has been licensed for use by the Schwab International Index Fund. The Schwab International Index Fund is not sponsored, endorsed, sold or promoted by MSCI and MSCI bears no liability with respect to the fund. The Statement of Additional Information contains a more detailed description of the limited relationship MSCI has with the fund. It is the funds policy that under normal circumstances it will invest at least 80% of its net assets (including, for this purpose, any borrowings for investment purposes) in these stocks; typically, the actual percentage is considerably higher. The fund will notify its shareholders at least 60 days before changing this policy. The fund generally will seek to replicate the performance of the index…
From the fund's prospectus (filed Feb 26, 2026).
SWISX performance
| 1 yr | 5 yr | 10 yr | |
|---|---|---|---|
| SWISX | +31.6% | +9.0% | +8.3% |
| International Stock median | +25.5% | +6.4% | +7.6% |
Source: Fund prospectus, as of Dec 31, 2025
What SWISX costs
On a $10,000 investment, SWISX's 0.06% expense ratio costs about $6 a year. The prospectus estimates $77 in total costs over 10 years (assuming 5% annual returns). The median international stock fund charges 0.9%.
SWISX top 10 holdings
| # | Holding | % of fund |
|---|---|---|
| 1 | ASML Holding NV | 2.58% |
| 2 | Roche Holding AG | 1.48% |
| 3 | HSBC Holdings PLC | 1.41% |
| 4 | AstraZeneca PLC | 1.34% |
| 5 | Novartis AG | 1.30% |
| 6 | Nestle SA | 1.14% |
| 7 | Siemens AG | 1.06% |
| 8 | Shell PLC | 1.03% |
| 9 | Toyota Motor Corp | 0.99% |
| 10 | Sap Se | 0.96% |
Source: SEC Form N-PORT, period ended Jan 31, 2026
The top 10 make up 13.3% of the fund. See all top 25 holdings and asset mix →
Alternatives to SWISX
| Family | Fund | Expense ratio | Overlap | |
|---|---|---|---|---|
| Fidelity | FSPSX Fidelity International Index Fund | 0.035% | 80% | Compare |
| J.P. Morgan | BBIN JPMorgan BetaBuilders International… | 0.07% | 82% | Compare |
| SPDR (State Street) | EFAX State Street(R) SPDR(R) MSCI EAFE… | 0.2% | 68% | Compare |
| T. Rowe Price | PIEQX T. Rowe Price International Equity… | 0.25% | 76% | Compare |
| iShares | EFA iShares MSCI EAFE ETF | 0.32% | 82% | Compare |